July 8 (Reuters) - COSMO PHARMACEUTICALS NV:

* ANNOUNCES GRANTING OF MARKETING AUTHORIZATION IN ITALY TO RIFAMYCIN SV MMX (STADMYCIN™) BY ITALIAN AIFA

* WILL RECEIVE A MILESTONE PAYMENT OF EUR 1.5M FROM E.G. DUE ON GRANT OF THIS MARKETING AUTHORIZATION Source text for Eikon: Further company coverage: (Gdansk Newsroom)

Source: Reuters

Powered by NewsAPI.org